Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1970
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1974 3
1975 3
1976 1
1978 1
1979 2
1980 3
1981 3
1982 2
1983 3
1984 2
1985 4
1986 4
1987 4
1988 8
1989 24
1990 25
1991 21
1992 19
1993 17
1994 12
1995 23
1996 17
1997 26
1998 26
1999 18
2000 19
2001 17
2002 10
2003 30
2004 23
2005 31
2006 20
2007 19
2008 28
2009 26
2010 28
2011 17
2012 28
2013 31
2014 24
2015 34
2016 37
2017 42
2018 30
2019 24
2020 22
2021 29
2022 39
2023 32
2024 37
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

880 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Classification, Screening and Diagnosis for Thalassemia.
Viprakasit V, Ekwattanakit S. Viprakasit V, et al. Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006. Hematol Oncol Clin North Am. 2018. PMID: 29458726 Review.
At present, thalassemia diseases are classified into transfusion-dependent thalassemia and non-transfusion-dependent thalassemia. This classification is based on the clinical severity of patients determining whether they do require regular blood transfusions …
At present, thalassemia diseases are classified into transfusion-dependent thalassemia and non-transfusion-dependent thalas
Alpha and beta thalassemia.
Muncie HL Jr, Campbell J. Muncie HL Jr, et al. Am Fam Physician. 2009 Aug 15;80(4):339-44. Am Fam Physician. 2009. PMID: 19678601 Free article. Review.
Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with alpha or beta thalassemia trait are asymptomatic and require no treatment. Alpha thalassemia intermedia, or hemog …
Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with …
beta-Thalassemia.
Origa R. Origa R. Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3. Genet Med. 2017. PMID: 27811859 Free article. Review.
Three clinical and hematological conditions of increasing severity are recognized: the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major, a severe transfusion-dependent anemia. ...Factors include the inheritance of mild/silent beta …
Three clinical and hematological conditions of increasing severity are recognized: the beta-thalassemia carrier state, thalassemia
Molecular basis of alpha-thalassemia.
Farashi S, Harteveld CL. Farashi S, et al. Blood Cells Mol Dis. 2018 May;70:43-53. doi: 10.1016/j.bcmd.2017.09.004. Epub 2017 Sep 21. Blood Cells Mol Dis. 2018. PMID: 29032940 Free article. Review.
alpha-Thalassemia is an inherited, autosomal recessive, disorder characterized by a microcytic hypochromic anemia. ...Deletions and point mutations in the alpha-globin genes and their regulatory elements have been studied extensively in carriers and patients
alpha-Thalassemia is an inherited, autosomal recessive, disorder characterized by a microcytic hypochromic anemia. ...Deletion
The alpha-thalassemias.
Piel FB, Weatherall DJ. Piel FB, et al. N Engl J Med. 2014 Nov 13;371(20):1908-16. doi: 10.1056/NEJMra1404415. N Engl J Med. 2014. PMID: 25390741 Free article. Review.
More than 100 varieties of alpha-thalassemia have been identified. Their geographic distribution and the challenges associated with screening, diagnosis, and management suggest that alpha-thalassemias should have a higher priority on global public health agen …
More than 100 varieties of alpha-thalassemia have been identified. Their geographic distribution and the challenges associated …
alphalpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT. Musallam KM, et al. Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3. Blood Rev. 2024. PMID: 38182489 Free article. Review.
alpha-Thalassemia is an inherited blood disorder characterized by decreased synthesis of alpha-globin chains that results in an imbalance of alpha and beta globin and thus varying degrees of ineffective erythropoiesis, decreased red blood cell (RBC) su
alpha-Thalassemia is an inherited blood disorder characterized by decreased synthesis of alpha-globin chains that resul
Sickle Cell Disease.
Piel FB, Steinberg MH, Rees DC. Piel FB, et al. N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865. N Engl J Med. 2017. PMID: 28423290 Free article. Review. No abstract available.
The Clinical Phenotypes of Alpha Thalassemia.
Lal A, Vichinsky E. Lal A, et al. Hematol Oncol Clin North Am. 2023 Apr;37(2):327-339. doi: 10.1016/j.hoc.2022.12.004. Hematol Oncol Clin North Am. 2023. PMID: 36907606 Review.
Clinical manifestations of alpha-thalassemia range from no symptoms to severe transfusion-dependent anemia. Alpha thalassemia trait is deletion of 1 to 2 alpha-globin genes, whereas alpha-thalassemia major (ATM; Barts hydrops fetal …
Clinical manifestations of alpha-thalassemia range from no symptoms to severe transfusion-dependent anemia. Alpha th
Thalassemia in Indonesia.
Wahidiyat PA, Sari TT, Rahmartani LD, Iskandar SD, Pratanata AM, Yapiy I, Setianingsih I, Atmakusuma TD, Lubis AM. Wahidiyat PA, et al. Hemoglobin. 2022 Jan;46(1):39-44. doi: 10.1080/03630269.2021.2023565. Hemoglobin. 2022. PMID: 35950580 Review.
Indonesia is located along the 'Thalassemia Belt' and a hotspot for hemoglobinopathies. Around 3.0-10.0% of the population carry beta-thalassemia (beta-thal) and 2.6-11.0% of the population carry alpha-thalassemia (alpha-thal). ...In line with t …
Indonesia is located along the 'Thalassemia Belt' and a hotspot for hemoglobinopathies. Around 3.0-10.0% of the population carry beta …
Laboratory diagnosis of thalassemia.
Brancaleoni V, Di Pierro E, Motta I, Cappellini MD. Brancaleoni V, et al. Int J Lab Hematol. 2016 May;38 Suppl 1:32-40. doi: 10.1111/ijlh.12527. Epub 2016 May 16. Int J Lab Hematol. 2016. PMID: 27183541 Review.
HbA2 determination is the most decisive test for beta-carrier detection although it can be disturbed by the presence of delta-thalassemia defects. In alpha-thalassemia, HbA2 can be lower than normal and it assumes significant value when iron deficiency is exc …
HbA2 determination is the most decisive test for beta-carrier detection although it can be disturbed by the presence of delta-thalassemia
880 results